There is no doubt that this is good news: on February 7, the European Parliament approved the Commission’s regulatory proposal on New Genomic Techniques, covering also CRISPR plants. Some of the approved amendments (particularly the one on genetic modification of polyploid plants) have the effect of improving the text, others risk being a problem and should be reconsidered during the trilogue with member states (particularly the requirement to label all final products, even if they do not contain foreign genes). The European Parliament also brought in the issue of non-patentability of NGT plants, which would deserve to be addressed elsewhere. For more information, this is the position expressed on February 14 by European Plant Science Organisation (EPSO).
Tag Archives: patents
Food, health and IP rights – CRISPR latest news
Two papers and a news item not to be missed. The first one is “Genome-edited powdery mildew resistance in wheat without growth penalties” published in Nature by a Chinese team led by Caixia Gao.
Continue readingSinging in the Lab
If you enjoyed “Bring me a gene” by Tim Blais and wished your friends “A Merry Little CRISPR”, be sure not to miss “The Patent” by Rob Nichols. It’s a parody of “Obedient Servant” from the musical Hamilton by Lin-Manuel Miranda, “based on the actual events of the CRISPR Revolutionary War”. For an IP update, please see this press-release announcing the 20th CRISPR patent awarded to UC Berkeley.
Nature Biotechnology features the explosion of Chinese biotech
China is the “Innovation Nation” and “The next biotech superpower”, according to the November issue of Nature Biotechnology. Beijing is “set to challenge the pre-eminence of the US drug market. If it can address gaps in its R&D ecosystem and clinical infrastructure, it may even become a home for biotech innovators”, says the editorial.
Continue reading